Regulation of IL-17A–mediated hypersensitivity by extracellular vesicles and lipid nanoparticles carrying miR-451a
The Journal of Immunology · 2025
DOI: 10.1093/jimmun/vkae049 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Takanobu Yoshida und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Faculty of Life Sciences, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. Hauptthemen laut MEDLINE: MicroRNAs, Extracellular Vesicles, Interleukin-17, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Ministry of Education, Culture, Sports, Science, and Technology, Japan Agency for Medical Research and Development, Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology.
Abstract (Originalsprache)
Extracellular vesicles (EVs), including exosomes, mediate intercellular communication by transporting functional molecules between donor cells and recipient cells, thereby regulating biological processes, such as immune responses. miR-451a, an immune regulatory microRNA, is highly abundant in circulating EVs; however, its precise physiological significance remains to be fully elucidated. Here, we demonstrate that miR-451a deficiency exacerbates delayed-type hypersensitivity (DTH) in mice. Notably, miR-451a knockout resulted in a significant increase in the number of interleukin (IL)-17A–expressing T helper 17 and γδ T cells infiltrating DTH-induced ear lesions. miR-451a deficiency also increased the number of γδ T cells in the secondary lymphoid tissues. Comprehensive analyses revealed that miR-451 deficiency promoted the expression of Rorc and γδ T cell–related genes following sensitization with allergens. Moreover, intravenous administration of wild-type EVs to miR-451a knockout mice increased cellular miR-451a levels in tissues and significantly attenuated the severity of DTH. Furthermore, synthetic lipid nanoparticles encapsulating miR-451a effectively mitigated DTH. Our findings indicate the importance of circulating miR-451a in the proliferation of γδ T cells and highlight the therapeutic potential of lipid nanoparticle–based microRNA delivery platforms for interventions in immune-related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Faculty of Life Sciences, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
- Department of Pediatrics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
ORCID-Profile: Ken Takashima, Yusuke Miyashita, Asuka Iwamoto
Förderung
- Ministry of Education, Culture, Sports, Science, and Technology
- Japan Agency for Medical Research and Development
- Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology
- T-CReDo
Zitieren
APA
Yoshida, T., Takashima, K., Mtali, Y. S., Miyashita, Y., Iwamoto, A., Fukushima, Y., Nakamura, K., & Oshiumi, H. (2025). Regulation of IL-17A–mediated hypersensitivity by extracellular vesicles and lipid nanoparticles carrying miR-451a. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkae049
Vancouver
Yoshida T, Takashima K, Mtali YS, Miyashita Y, Iwamoto A, Fukushima Y, et al. Regulation of IL-17A–mediated hypersensitivity by extracellular vesicles and lipid nanoparticles carrying miR-451a. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkae049
BibTeX
@article{Yoshida2025,
author = {Yoshida, Takanobu and Takashima, Ken and Mtali, Yohana S and Miyashita, Yusuke and Iwamoto, Asuka and Fukushima, Yoshimi and Nakamura, Kimitoshi and Oshiumi, Hiroyuki},
title = {Regulation of IL-17A–mediated hypersensitivity by extracellular vesicles and lipid nanoparticles carrying miR-451a},
journal = {The Journal of Immunology},
year = {2025},
doi = {10.1093/jimmun/vkae049}
}
EUVIMED